Surgical Antibiotic Prophylaxis in an Era of Antibiotic Resistance: Common Resistant Bacteria and Wider Considerations for Practice
Open accessThe DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The increasing incidence of antimicrobial resistance (AMR) presents a global crisis to healthcare, with longstanding antimicrobial agents becoming less effective at treating and preventing infection. In the surgical setting, antibiotic prophylaxis has long been established as routine standard of care to prevent surgical site infection (SSI), which remains one of the most common hospital-acquired infections. The growing incidence of AMR increases the risk of SSI complicated with resistant bacteria, resulting in poorer surgical outcomes (prolonged hospitalisation, extended durations of antibiotic therapy, higher rates of surgical revision and mortality). Despite these increasing challenges, more data are required on approaches at the institutional and patient level to optimise surgical antibiotic prophylaxis in the era of antibiotic resistance (AR). This review provides an overview of the common resistant bacteria encountered in the surgical setting and covers wider considerations for practice to optimise surgical antibiotic prophylaxis in the perioperative setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Where interventions such as AMS have been implemented in surgery, their focus remains on surgical antibiotic prophylaxis and prevention of surgical site infection (SSI).10,11”
From Rationalizing irrational prescribing—infection-related attitudes and practices across paediatric surgery specialties in a hospital in South India (2024) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
A surgical safety checklist to reduce morbidity and mortality in a global population
Haynes, A. B., Weiser, T. G., Berry, W. R., Lipsitz, S. R., Breizat, A.-H. S., Dellinger, E. P., Herbosa, T., Joseph, S., Kibatala, P. L., Lapitan, M. C. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0810119 · Cited by 5,688 · cited 1×
“003).(129) The current WHO SSC (2009) aims to achieve SAP within 60 minutes prior to incision and assessment of patient allergies, both of which optimise appropriate antibiotic use.”
BackgroundWisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“faecium isolates displaying resistance to vancomycin.(47) While there are many phenotypes of resistance within the Enterococcus spp.”
BackgroundMultistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Berríos-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., Reinke, C. E., Morgan, S., Solomkin, J. S., Mazuski, J. E., et al. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0904 · Cited by 3,569 · cited 1×
“be used when appropriate and should follow established guidelines.(109) Despite these influential recom-”
MethodExtended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
Cassini, A., Högberg, L. D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G. S., Colomb-Cotinat, M., Kretzschmar, M. E., Devleesschauwer, B., Cecchini, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30605-4 · Cited by 2,945 · cited 1×
“throughout Europe, it is estimated that approximately 33,000 patients die each year due to drug-resistant infections, of which more than half are healthcare-acquired.(11) The actual world-wide prevalence of people affected with”
BackgroundThe Epidemiology of Obesity: A Big Picture
Hruby, A., & Hu, F. B. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0243-x · Cited by 2,916
Clinical practice guidelines for antimicrobial prophylaxis in surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120568 · Cited by 2,591 · cited 15×
“timing of administration) will have increasing importance (Figure 2).(19) AMS programs are also effective in”
BackgroundInfluentialUpdated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367 · cited 4×
“Three groups, defined by Bush et al, include the following: group 1 (cephalosporinases), group 2 (serine ßlactamases) and group 3 (metallo-ß-lactamases).(54) Group 1 and 2 ß-lactamases hydrolyse the ß-lactam antibiotic via serine mediated catabolism of the ß-lactamase enzyme active site, whereas group 3 metallo-ß-lact…”
BackgroundInfluentialJacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165 · cited 2×
“AmpCmediated resistance occurs by hydrolysis of narrow spectrum cephalosporins (cefazolin, cefalexin), though increased and repeated exposure to cephalosporins can induce AmpC production – leading to resistance to broader-spectrum cephalosporins ceftriaxone, ceftazidime and cefotaxime.(58) This is concerning as common…”
BackgroundInterventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Self-citationThe Timing of Prophylactic Administration of Antibiotics and the Risk of Surgical-Wound Infection
Classen, D. C., Evans, R. S., Pestotnik, S. L., Horn, S. D., Menlove, R. L., & Burke, J. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260501 · Cited by 1,739
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282 · cited 1×
“Further, coexistence of resistance to quinolones can occur by reduced membrane permeability and/or overexpression of drug efflux pumps.(76) Recent exposure to quinolones (surgical prophylaxis or treatment) is a known risk factor for acquired quinolone resistance.”
BackgroundCosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271 · cited 1×
“While the emergence of AMR occurs across the microbiome, bacterial resistance poses the greatest threat with longstanding antibiotics becoming less effective at treating and preventing bacterial infection, resulting in poorer patient and surgical outcomes.(4,5) Globally, multiple factors contribute to increasing preva…”
BackgroundBratzler, D. W., & Houck, P. M. (2005) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2005.01.015 · Cited by 1,163 · cited 2×
“This allows appropriate time for peak concentration, distribution and penetration into the peripheral tissue and time above the MIC of the anticipated organism.(144) Evidence for administration of cefazolin <120 minutes prior to incision originated from a study in 1992 consisting of 2847 patients.”
BackgroundVancomycin-Resistant Enterococci
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686 · Cited by 1,163
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub4 · Cited by 1,068
Self-citationThe global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Surgical site infections: epidemiology, microbiology and prevention
Owens, C. D., & Stoessel, K. (2008) · Journal of Hospital Infection · doi:10.1016/s0195-6701(08)60017-1 · Cited by 987 · cited 2×
“first-line narrow spectrum penicillins and cephalosporins (flucloxacillin, nafcillin, cefazolin).(16,35) While the long-”
BackgroundThe worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966 · cited 1×
“QnrA, qnrB and qnrS prevent quinolone effects at DNA gyrase/topoisomerase IV and are hypothesised to contribute and potentiate quinolone resistance, though their effect is not entirely understood.(79,80) Resistance to quinolones is increasing globally, threatening many elements of modern medicine including SAP.”
BackgroundMacy, E., & Contreras, R. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.021 · Cited by 829
How to manage Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B. (2018) · Drugs in Context · doi:10.7573/dic.212527 · Cited by 746 · cited 3×
“ß-lactamase production can render cephalosporin, penicillin and carbapenem type ß-lactam antibiotics ineffective.51 Carriage with resistant Enterobacterales is increasing, with common examples of ß-lactamase-producing organisms including E. coli, Klebsiella spp, and Enterobacter spp.51 In addition to Enterobacterales,…”
BackgroundInfluentialMechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716 · cited 2×
“to mutations of DNA gyrase subunits GyrA/GyrB and/or topoisomerase IV subunit ParC/ParE.(75) Further, coexistence of resistance to quinolones can occur by reduced membrane permeability and/or overexpression of drug efflux pumps.”
BackgroundInfluentialRuiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711 · cited 2×
“nolones also target topoisomerase IV, inhibiting the relaxation of coiled DNA.(74) Resistance occurs predominantly due”
BackgroundInfluentialBiccard, B. M., Madiba, T. E., Kluyts, H.-L., Munlemvo, D. M., Madzimbamuto, F. D., Basenero, A., Gordon, C. S., Youssouf, C., Rakotoarison, S. R., Gobin, V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30001-1 · Cited by 580 · cited 1×
“In low-income and middle-income countries, risk of SSI and postoperative mortality is greater than high-income countries.(29) In the perioperative period, factors influencing SSI risk include availability, selection of antibiotic, timing and dose of antibiotic agent, and appropriate antiseptic preparation of the skin.”
BackgroundStaphylococcus aureus resistant to vancomycin--United States, 2002.
(2002) · PubMed · Cited by 569
Interplay between β-lactamases and new β-lactamase inhibitors
Bush, K., & Bradford, P. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0159-8 · Cited by 531
Cong, Y., Yang, S., & Rao, X. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 527 · cited 2×
“requiring antibiotic treatment with daptomycin, linezolid, ceftaroline or tigecycline.(42,45)”
BackgroundMetallo‐β‐lactamase structure and function
Palzkill, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06796.x · Cited by 505 · cited 1×
“Group 3, Class B metallo-ß-lactamases (MBL), differ functionally and structurally to their serine counterparts by the presence of zinc 2 at the enzyme active site.(70) Common representative enzymes and variants (IMP,”
BackgroundThe impact of a reported penicillin allergy on surgical site infection risk.
Blumenthal, K. G., Ryan, E. E., Li, Y., Lee, H., Kuhlen, J. L., & Shenoy, E. S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix794 · Cited by 481 · cited 9×
“Narrower spectrum first-generation cephalosporins (ie, cefazolin) are common antibiotics utilised for SAP.”
MethodInfluentialBhangu, A., Ademuyiwa, A. O., Aguilera, M. L., Alexander, P., Al-Saqqa, S. W., Borda-Luque, G., Costas-Chavarri, A., Drake, T. M., Ntirenganya, F., Fitzgerald, J. E., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30101-4 · Cited by 478 · cited 2×
“6%) in highHDI countries.(21) AR is a threat across both primary healthcare (general/ family practice, residential aged care facilities), secondary and tertiary care (hospitalisations).”
BackgroundBen‐Ami, R., Rodríguez‐Baño, J., Arslan, H., Pitout, J. D. D., Quentin, C., Calbo, E. S., Azap, Ö. K., Arpin, C., Pascual, A., Livermore, D. M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604713 · Cited by 462
Charani, E., Castro-Sanchez, E., Sevdalis, N., Kyratsis, Y., Drumright, L., Shah, N., & Holmes, A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit212 · Cited by 455 · cited 9×
“Narrower spectrum first-generation cephalosporins (ie, cefazolin) are common antibiotics utilised for SAP.”
BackgroundInfluentialSelf-citationQuinolones: a comprehensive review.
Oliphant, C. M., & Green, G. M. (2002) · PubMed · Cited by 454
A Systematic Review of Risk Factors Associated with Surgical Site Infections among Surgical Patients
Korol, E., Johnston, K., Waser, N., Sifakis, F., Jafri, H. S., Lo, M., & Kyaw, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083743 · Cited by 450 · cited 1×
“Patient-Specific Risk Factors for SSI Patient-specific risk factors such as older age, obesity, active smoking status, medical comorbidities, ASA-grade and use of immunosuppressive drugs can influence the risk of SSI and postoperative mortality.(27,28) In low-income and middle-income countries, risk of SSI and postope…”
BackgroundThe cost of antimicrobial resistance
Hofer, U. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0125-x · Cited by 427 · cited 1×
“5 billion annually.(14) Longer term, the cumulative global expenditure”
BackgroundMethicillin Resistance in Staphylococcus Aureus: Mechanisms and Modulation
Stapleton, P. D., & Taylor, P. W. (2002) · Science Progress · doi:10.3184/003685002783238870 · Cited by 416 · cited 1×
“penicillin binding protein 2a (PBP2a).(36) Vancomycin”
STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200203000-00016 · Cited by 395
Branch-Elliman, W., O’Brien, W., Strymish, J., Itani, K., Wyatt, C., & Gupta, K. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.0569 · Cited by 381
Risk Factors for Surgical Site Infection
Cheadle, W. G. (2006) · Surgical Infections · doi:10.1089/sur.2006.7.s1-7 · Cited by 329 · cited 3×
“During surgery, physiological factors affecting the risk of SSI include the presence of hyperglycaemia, trauma, shock, requirement for blood transfusion, hypoxia and hypothermia.(28) In addition, some patients may be known or at risk of carriage of multidrug-resistant organisms (MROs), which preclude the use of first-…”
BackgroundShariati, A., Dadashi, M., Moghadam, M. T., van Belkum, A., Yaslianifard, S., & Darban-Sarokhalil, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-69058-z · Cited by 329 · cited 2×
“The emergence of MRSA dates back to the mid-20th century where isolates of S. aureus showed alterations to penicillin binding protein 2a (PBP2a).36 Vancomycin overcomes this resistance mechanism by targeting an alternate pathway via inhibition of S. aureus peptidoglycan synthesis.37 Nowadays, the use of vancomycin is…”
BackgroundInfluentialPhage therapy as a potential solution in the fight against AMR: obstacles and possible futures
Brives, C., & Pourraz, J. (2020) · Palgrave Communications · doi:10.1057/s41599-020-0478-4 · Cited by 322 · cited 2×
“%) patients.164 Hypothesised applications of bacteriophages in the surgical setting with topical application of phage solutions to a surgical wound before closure are proposed by Brives and Pourraz.165 The growing concerns of mupirocin resistant MRSA and difficulty in eradicating mucosal Staphylococcal carriage has sp…”
Influx of Extended-Spectrum -Lactamase--Producing Enterobacteriaceae into the Hospital
Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., & Carmeli, Y. (2006) · Clinical Infectious Diseases · doi:10.1086/500936 · Cited by 317
Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria
Arnold, R. S., Thom, K. A., Sharma, S., Phillips, M., Kristie Johnson, J., & Morgan, D. J. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e3181fd7d5a · Cited by 307 · cited 1×
“).(65) The presence of KPC-producing bacteria hinders”
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong, T., Salabarria, A.-C., & Roach, D. R. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.07.014 · Cited by 266 · cited 1×
“are viruses with restricted bacterial activity often resulting in bacterial cell lysis.(163) To date, application and evidence of bacteriophage therapy is limited to small case studies and experimental trials.”
BackgroundCarbapenem-Resistant Enterobacteriaceae
Iovleva, A., & Doi, Y. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.01.005 · Cited by 263
Vancomycin‐Resistant Enterococci: Mechanisms and Clinical Observations
Gold, H. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321815 · Cited by 258
Brem, J., Cain, R., Cahill, S., McDonough, M. A., Clifton, I. J., Jiménez-Castellanos, J.-C., Avison, M. B., Spencer, J., Fishwick, C. W. G., & Schofield, C. J. (2016) · Nature Communications · doi:10.1038/ncomms12406 · Cited by 255
Differential Drivers of Antimicrobial Resistance across the World
Vikesland, P., Garner, E., Gupta, S., Kang, S., Maile-Moskowitz, A., & Zhu, N. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00643 · Cited by 254 · cited 1×
“Globally, multiple factors contribute to increasing prevalence of antibioticresistant organisms, including social determinants, economic factors, provision and governance of healthcare, and environmental factors, all of which impact on both humans and animals.(6,7) Additionally, inappropriate antibiotic use is becomin…”
BackgroundVancomycin-resistant Staphylococcus aureus--New York, 2004.
(2004) · PubMed · Cited by 252
The ABCD’s of β-lactamase nomenclature
Bush, K. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-013-0640-7 · Cited by 239 · cited 1×
“ßlactamases exist in molecular subclasses A, B, C and D, determined by amino acid sequence, of which each resistance profile can be grouped by phenotype and bacterial isolate.(53) Three groups, defined by Bush et al, include the following: group 1 (cephalosporinases), group 2 (serine ßlactamases) and group 3 (metallo-…”
BackgroundB1-Metallo-β-Lactamases: Where Do We Stand?
F. Mojica, M., A. Bonomo, R., & Fast, W. (2016) · Current Drug Targets · doi:10.2174/1389450116666151001105622 · Cited by 215
Fecal microbiota transplantation in relapsing Clostridium difficile infection
Rohlke, F., & Stollman, N. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12453637 · Cited by 211 · cited 1×
“Treatment outcomes in these patients are showing response rates in approximately 90% of the cases.(167)”
BackgroundAnahtar, M. N., Yang, J. H., & Kanjilal, S. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01260-20 · Cited by 211 · cited 2×
“predict the presence of resistance by using genomic data, assisting the clinician with early diagnosis, prevention and provide guidance on treatment options.(161) Early-stage trials within ICU departments in Greece have used”
BackgroundMethodBischoff, P., Kubilay, N. Z., Allegranzi, B., Egger, M., & Gastmeier, P. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30059-2 · Cited by 203 · cited 1×
“mented in some high-income settings to support reduction in SSI, although their effectiveness has been questioned.(32)”
BackgroundPalzkill, T. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00016 · Cited by 199 · cited 1×
“the efficacy of antibiotics used for SAP, as routine cephalosporins are precluded by class-A ß-lactamase hydrolysis.(68) SAP in such instances may require sensitivity-guided/-targeted prophylaxis or combinations of ami-”
de Jonge, S. W., Gans, S. L., Atema, J. J., Solomkin, J. S., Dellinger, P. E., & Boermeester, M. A. (2017) · Medicine · doi:10.1097/md.0000000000006903 · Cited by 198 · cited 1×
“A subsequent metaanalysis of over 54,552 patients (from 14 studies) concurred with this finding.(146) The timing of vancomycin and fluoroquinolone administration for SAP differs to cephalosporin due to the increased infusion time required with these agents.”
Lahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197 · cited 1×
“Recent advances have seen the advent of the ß-lactamase inhibitor avibactam, which is used in combination with broad spectrum cephalosporin agent ceftazidime in attempts to provide efficacy for AmpC-mediated resistance.(61) Group 2 serine ß-lactamases consist of molecular subclasses A and D, with common representative…”
BackgroundBlumenthal, K. G., Shenoy, E. S., Varughese, C. A., Hurwitz, S., Hooper, D. C., & Banerji, A. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.05.011 · Cited by 185 · cited 1×
“This approach narrowed the spectrum of SAP used (reducing the use of vancomycin, aztreonam, fluoroquinolones, and aminoglycosides), with no reported increase in adverse drug reactions (type and/or severity).(89) In a US study, preoperative penicillin allergy skin testing was performed in patients self-reporting penici…”
MethodAdeme, M. (2020) · doi:10.2147/idr.s249864 · Cited by 182 · cited 1×
“Resistance has been highlighted in recent times to various microbes, including fungal infection with Candida auris, which is showing growing resistance to many first-line anti-fungal treatments.(3) AMR is set to exceed current annual cancerrelated deaths world-wide by 2050.”
BackgroundConfronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
Strathdee, S. A., Davies, S. C., & Marcelin, J. R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32063-8 · Cited by 181 · cited 1×
“from a drug-resistant infection each year in the US alone, and 35,000 of these subsequently dying.(10) Similarly,”
BackgroundManagement of KPC-producing Klebsiella pneumoniae infections
Bassetti, M., Giacobbe, D. R., Giamarellou, H., Viscoli, C., Daikos, G. L., Dimopoulos, G., De Rosa, F. G., Giamarellos-Bourboulis, E. J., Rossolini, G. M., Righi, E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.030 · Cited by 175 · cited 1×
“noglycosides, polymyxins, tigecycline, fosfomycin or ceftazidime/avibactam.(69) Group 3, Class B metallo-ß-lactamases (MBL), differ functionally and structurally to their serine counterparts by the presence of zinc 2 at the enzyme active site.”
BackgroundBacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery
Rubalskii, E., Ruemke, S., Salmoukas, C., Boyle, E. C., Warnecke, G., Tudorache, I., Shrestha, M. L., Schmitto, J. D., Martens, A., Rojas, S. V., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9050232 · Cited by 172
Zelenitsky, S. A., Ariano, R. E., Harding, G. K. M., & SILVERMAN, R. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3026-3030.2002 · Cited by 163 · cited 2×
“This is done to ensure serum and tissue concentrations exceed the microbial minimum inhibitory concentration (MIC) throughout the duration of surgery.(100,101) Common examples include procedure durations exceeding two half-lives of the SAP utilised or in procedures where there is excessive blood loss, exceeding 1500mL.”
BackgroundDosing of antibiotics in obesity
Janson, B., & Thursky, K. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328359a4c1 · Cited by 160 · cited 1×
“Obesity influences the pharmacokinetic disposition of common antibiotics used in SAP by alterations in volume of distribution, hepatic metabolism, renal clearance and protein binding, resulting in less predictable antibiotic exposure.(93,94) In attempts to ensure adequate SAP dosage that provides sufficient tissue con…”
Backgroundde Jonge, S. W., Boldingh, Q. J. J., Solomkin, J. S., Dellinger, E. P., Egger, M., Salanti, G., Allegranzi, B., & Boermeester, M. A. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30084-0 · Cited by 158 · cited 1×
“the effect of post-operative continuation of SAP has demonstrated no benefits over single-dose therapy.(159) Therefore, we need to communicate the risks associated with prolonged antibiotic use more effectively with surgi-”
BackgroundIntraoperative Redosing of Cefazolin and Risk for Surgical Site Infection in Cardiac Surgery
Zanetti, G., Giardina, R., & Platt, R. G. (2001) · Emerging infectious diseases · doi:10.3201/eid0705.017509 · Cited by 155 · cited 1×
“adopted in prolonged cardiac surgery, where a 16% reduction in SSI has been demonstrated.(103) An important study con-”
A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century
Paskovaty, A., Pflomm, J.-M., Myke, N., & Seo, S. K. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.001 · Cited by 154 · cited 1×
“plinary teams is likely to remain fundamental to mitigate AR and limit SSI with resistant organisms.(170) Future”
BackgroundComprehensive Guidance for Antibiotic Dosing in Obese Adults
Meng, L., Mui, E., Holubar, M. K., & Deresinski, S. C. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2023 · Cited by 153 · cited 1×
“However, it is important to note there is a lack of well-established and robust data on dosing antibiotics in obesity, as many studies have small sample sizes, are subject to heterogenous data and often provide conflicting results.(96) Appropriate dose alteration should be balanced, comparing the risk of over-exposure…”
BackgroundCharani, E., Ahmad, R., Rawson, T. M., Castro-Sanchèz, E., Tarrant, C., & Holmes, A. H. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy844 · Cited by 152 · cited 1×
“surgical teams in relation to antibiotic decision-making, including an individualistic and hierarchical culture, which may limit integrated care in surgical pathways.(151,152) Historically, AMS initiatives have over-”
BackgroundSelf-citationDoes Intraoperative Blood Loss Affect Antibiotic Serum and Tissue Concentrations?
Swoboda, S. M. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430230047009 · Cited by 147
Remschmidt, C., Schröder, C., Behnke, M., Gastmeier, P., Geffers, C., & Kramer, T. S. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0353-x · Cited by 144
Studies on the duration of antibiotic administration for surgical prophylaxis.
Scher, K. S. (1997) · PubMed · Cited by 140
Structural modifications of glycopeptide antibiotics
Malabarba, A., Nicas, T. I., & Thompson, R. C. (1997) · Medicinal Research Reviews · Cited by 140
Charani, E., Smith, I., Skodvin, B., Perozziello, A., Lucet, J.-C., Lescure, F.-X., Birgand, G., Poda, A., Ahmad, R., Singh, S., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0209847 · Cited by 139 · cited 1×
“looked surgical specialties, with the notion that surgical teams are more difficult to engage with.(153) Where they do exist, the focus has been on SSI prevention and SAP.”
BackgroundSelf-citationPark, M., Markus, P. J., Matešić, D., & Li, J. T. C. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61100-3 · Cited by 137 · cited 1×
“In those patients with reported penicillin allergy, only 4% demonstrated a true reaction to penicillin, resulting in a significant reduction of empirical vancomycin use from 30% to 16%.(90)”
BackgroundThe Mechanisms of Catalysis by Metallo β‐Lactamases
Page, M. I., & Badarau, A. (2008) · Bioinorganic Chemistry and Applications · doi:10.1155/2008/576297 · Cited by 129
Economics of antibiotic resistance
Sıpahı, O. R. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.4.523 · Cited by 125 · cited 1×
“revision, and requirement for novel antibiotics which may have increased toxicity.(13) Across the United States, Europe”
BackgroundDrug-Induced Anaphylaxis Documented in Electronic Health Records
Dhopeshwarkar, N., Sheikh, A., Doan, R., Topaz, M., Bates, D. W., Blumenthal, K. G., & Zhou, L. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.06.010 · Cited by 121 · cited 1×
“While penicillin allergy labelling is associated with increased SSI, penicillin and sulphonamide antibiotics remain the most reported causes of drug-induced hypersensitivity and anaphylaxis; surgeons and anaesthetists should thus remain vigilant in ensuring true penicillin allergy is managed appropriately.(88) Steps t…”
BackgroundLautenbach, E., Fishman, N. O., Bilker, W. B., Castiglioni, A., Metlay, J. P., Edelstein, P. H., & Strom, B. L. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2469 · Cited by 120 · cited 1×
“Recent exposure to quinolones (surgical prophylaxis or treatment) is a known risk factor for acquired quinolone resistance.(77) A meta-analysis by Zhu et al highlights the significant increase of resistance of E.”
BackgroundFeretzakis, G., Loupelis, E., Sakagianni, A., Kalles, D., Martsoukou, M., Lada, M., Skarmoutsou, N., Christopoulos, C., Valakis, K., Velentza, A., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9020050 · Cited by 112
Miliani, K., L'Hériteau, F., & Astagneau, P. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp367 · Cited by 112
Antimicrobial resistance development following surgical site infections
Călina, D. C., Docea, A. O., Roşu, L., Zlatian, O. M., Rosu, A. F., Anghelina, F., Rogoveanu, O. C., Arsene, A. L., Nicolae, A. C., Drăgoi, C. M., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6034 · Cited by 109 · cited 1×
“Infection with resistant Klebsiella pneumoniae, Proteus mirabilis, Enterobacter aerogenes, and non-fermenting Gram-negative bacterial infections also regularly occur.(23) Antibiotic selection for SAP is dependent on local resistance patterns and institutional protocols, though most SAP regimens are selected by their s…”
BackgroundPonce, B., Raines, B. T., Reed, R. D., Vick, C., Richman, J., & Hawn, M. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.m.00663 · Cited by 107 · cited 1×
“In arthroplasty, the use of vancomycin as a sole agent in a cohort of patients (where 54% of the patients had a penicillin allergy) was associated with more SSI than prophylaxis with cefazolin in those without penicillin allergy.(86) Similarly, when patients labelled penicillin allergic undergoing head and neck surger…”
BackgroundPool, C., Kass, J., Spivack, J., Nahumi, N., Khan, M., Babus, L., Teng, M. S., Genden, E. M., & Miles, B. A. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815617129 · Cited by 103 · cited 1×
“Similarly, when patients labelled penicillin allergic undergoing head and neck surgery received clindamycin as an alternative to cephalosporins, SSIs increased four-fold.(87) While penicillin allergy labelling is associated with increased SSI, penicillin and sulphonamide antibiotics remain the most reported causes of…”
BackgroundUnderstanding antibiotic decision making in surgery—a qualitative analysis
Charani, E., Tarrant, C., Moorthy, K., Sevdalis, N., Brennan, L., & Holmes, A. H. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.013 · Cited by 101 · cited 1×
“surgical teams in relation to antibiotic decision-making, including an individualistic and hierarchical culture, which may limit integrated care in surgical pathways.(151,152) Historically, AMS initiatives have over-”
BackgroundSelf-citationClinical Importance and Epidemiology of Quinolone Resistance
Kim, E. S., & Hooper, D. C. (2014) · Infection and Chemotherapy · doi:10.3947/ic.2014.46.4.226 · Cited by 101 · cited 9×
“Narrower spectrum first-generation cephalosporins (ie, cefazolin) are common antibiotics utilised for SAP.”
BackgroundInfluentialThe SURgical PAtient Safety System (SURPASS) checklist optimizes timing of antibiotic prophylaxis
de Vries, E. N., Dijkstra, L., Smorenburg, S. M., Meijer, R. P., & Boermeester, M. A. (2010) · Patient Safety in Surgery · doi:10.1186/1754-9493-4-6 · Cited by 99
Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
Chen, L., Anderson, D. J., & Paterson, D. L. (2012) · Infection and Drug Resistance · doi:10.2147/idr.s26613 · Cited by 96
Antibiotics for surgical prophylaxis
Munckhof, W. (2005) · Australian Prescriber · doi:10.18773/austprescr.2005.030 · Cited by 94 · cited 3×
“The incidence of AMR is rapidly increasing and infection-related mortality is expected to exceed 10 million cases per year by 2050.1 Over the past decade, the emergence of AMR across fungal, viral, bacterial, and protozoal infections is increasingly reported.2 Resistance has been highlighted in recent times to various…”
BackgroundInfluentialGargiullo, L., CHIERICO, F. D., D’Argenio, P., & Putignani, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01704 · Cited by 89
Exploring obstacles to proper timing of prophylactic antibiotics for surgical site infections
Tan, J. A. (2006) · Quality and Safety in Health Care · doi:10.1136/qshc.2004.012534 · Cited by 86 · cited 2×
“gery (knife-to-skin time), route of administration, duration of surgery and unforeseen delays in surgery time.(19,111) Despite”
BackgroundBirgand, G., Castro‐Sánchez, E., Hansen, S., Gastmeier, P., Lucet, J., Ferlie, E. B., Holmes, A. H., & Ahmad, R. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0321-5 · Cited by 86 · cited 1×
“Globally, multiple factors contribute to increasing prevalence of antibioticresistant organisms, including social determinants, economic factors, provision and governance of healthcare, and environmental factors, all of which impact on both humans and animals.(6,7) Additionally, inappropriate antibiotic use is becomin…”
BackgroundPolso, A. K., Lassiter, J. L., & Nagel, J. L. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12200 · Cited by 85 · cited 2×
“In attempts to ensure adequate SAP dosage that provides sufficient tissue concentrations, minimise toxicity and prevent the development of antibiotic resistance, clinicians may need to tailor dosing to ideal body weight, lean body weight, or adjusted body weight recommendations.(93) Examples of antibiotics which may r…”
BackgroundChopra, T., Zhao, J., Alangaden, G. J., Wood, M. H., & Kaye, K. S. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.26 · Cited by 83 · cited 1×
“Examples of antibiotics which may require dose alteration in obesity include cefazolin, ceftriaxone, clindamycin, gentamicin, aztreonam, daptomycin and vancomycin.(95) However, it is important to note there is a lack of well-established and robust data on dosing antibiotics in obesity, as many studies have small sampl…”
ResultSurgical Antibiotic Prophylaxis and Risk for Postoperative Antibiotic-Resistant Infections
Cohen, M. E., Salmasian, H., Li, J., Liu, J., Zachariah, P., Wright, J. D., & Freedberg, D. E. (2017) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2017.08.010 · Cited by 83 · cited 1×
“cluded there was no risk of increased antibiotic resistance in their cohort.(125) Such data are promising for the use of”
BackgroundIerano, C., Thursky, K., Peel, T. N., Rajkhowa, A., Marshall, C. L., & Ayton, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225011 · Cited by 81 · cited 10×
“Narrower spectrum first-generation cephalosporins (ie, cefazolin) are common antibiotics utilised for SAP.”
BackgroundInfluentialPesesky, M. W., Hussain, T., Wallace, M. A., Wang, B., Andleeb, S., Burnham, C. D., & Dantas, G. A. (2015) · Emerging infectious diseases · doi:10.3201/eid2106.141504 · Cited by 80
Dubinsky‐Pertzov, B., Temkin, E., Harbarth, S., Fankhauser-Rodriguez, C., Carević, B., Radovanovic, I., Ris, F., Kariv, Y., Buchs, N. C., Schiffer, E. R. C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy768 · Cited by 79 · cited 1×
“71).(140) The increasing prevalence of fluoroquinolone resistance and the longstanding use for prophylaxis in transrectal prostate biopsy has received critique by the European Association of Urology, suggesting prescreening of these patients for fluoroquinolone resistance or the use of prophylactic Fosfomycin.”
BackgroundCarriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study
Pilmis, B., Cattoir, V., Lecointe, D., Limelette, A., Grall, I., Mizrahi, A., Marcadé, G., Poilane, I., Guillard, T., Bourgeois‐Nicolaos, N., et al. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.11.022 · Cited by 77 · cited 1×
“a prevalence of approximately 15%, which is expected to grow sharply over the coming years.(63) ESBLs show”
BackgroundMinimizing Surgical-Site Infections
Wenzel, R. P. (2010) · New England Journal of Medicine · doi:10.1056/nejme0908753 · Cited by 74 · cited 1×
“biome, remaining the most common organism associated with cutaneous infection.(33) It has widespread presence as”
BackgroundVancomycin for Surgical Prophylaxis?
Crawford, T., Rodvold, K. A., & Solomkin, J. S. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis027 · Cited by 74 · cited 5×
“We discuss common methods to optimise current surgical antibiotic prophylaxis (SAP) and highlight broader considerations for mitigating the risk of SSI in the setting of AR.”
BackgroundInfluentialLee, A. S., Cooper, B. S., Malhotra‐Kumar, S., Chalfine, A., Daikos, G. L., Fankhauser, C., Carević, B., Lemmen, S., Martínez, J. A., Aumatell, C. M., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003126 · Cited by 74
Implementation and evaluation of nationwide scale-up of the Surgical Safety Checklist
White, M. C., Randall, K., Capo‐Chichi, N., Sodogas, F., Quenum, S., Wright, K., Close, K. L., Russ, S., Sevdalis, N., & Leather, A. J. M. (2019) · British journal of surgery · doi:10.1002/bjs.11034 · Cited by 71
Self-citationBonkat, G., Pilatz, A. M. E., & Wagenlehner, F. R. A. (2019) · European Urology · doi:10.1016/j.eururo.2019.06.011 · Cited by 71 · cited 2×
“The increasing prevalence of fluoroquinolone resistance and the longstanding use for prophylaxis in transrectal prostate biopsy has received critique by the European Association of Urology, suggesting prescreening of these patients for fluoroquinolone resistance or the use of prophylactic Fosfomycin.(141) Recommendati…”
ResultInfluentialTherapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center
Grover, N., Sahni, A. K., & Bhattacharya, S. (2012) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2012.02.001 · Cited by 69 · cited 1×
“This is concerning as common ß-lactamase inhibitors such as clavulanic acid and tazobactam are generally ineffective at overcoming such resistance mechanisms and the presence of other resistance mechanisms such as extended-spectrum ßlactamases (ESBL) can co-exist.(59,60) Recent advances have seen the advent of the ß-l…”
BackgroundTavoukjian, V. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.03.010 · Cited by 69 · cited 1×
“risk of bias), small sample size (total 52 patients) and decolonisation was temporary.(169)”
BackgroundAssessment of operative times of multiple surgical specialties in a public university hospital
Costa, A. D. S. (2017) · Einstein (São Paulo) · doi:10.1590/s1679-45082017gs3902 · Cited by 67
Saied, T., Hafez, S. F., Kandeel, A., El-kholy, A., Ismail, G., Aboushady, M., Attia, E., Hassaan, A., Abdel-Atty, O., Elfekky, E., et al. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.07.004 · Cited by 64 · cited 2×
“01).(108) A study conducted in Ethiopia found that the recorded timing of SAP administration remained poor post-implementation of an institutional SAP protocol 69.”
BackgroundAbdelaziz, A., El-Menyar, A. A., Al-Thani, H. A. S., Zarour, A. M., Parchani, A., Asim, M., Enany, R. E., Al-Tamimi, H., & Latifi, R. (2013) · Advances in Pharmacological Sciences · doi:10.1155/2013/842593 · Cited by 64
Rezazadeh, M., Baghchesaraei, H., & Peymani, A. (2016) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2016.08.003 · Cited by 63 · cited 2×
“QnrA, qnrB and qnrS prevent quinolone effects at DNA gyrase/topoisomerase IV and are hypothesised to contribute and potentiate quinolone resistance, though their effect is not entirely understood.(79,80) Resistance to quinolones is increasing globally, threatening many elements of modern medicine including SAP.”
BackgroundPreoperative Staphylococcus Aureus Screening and Targeted Decolonization in Cardiac Surgery
Saraswat, M. K., Magruder, J. T., Crawford, T. C., Gardner, J. M., Duquaine, D. C., Sussman, M. S., Maragakis, L. L., & Whitman, G. J. R. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.03.018 · Cited by 63 · cited 1×
“86).(138) There are challenges with ß-lactamase-producing Enterobacterales, where bacterial carriage in the gastrointestinal tract limits the ability of decolonisation and is recognised in the WHO Surgical Site Infection”
BackgroundAntibiotic prescribing in general medical and surgical specialties: a prospective cohort study
Charani, E., de Barra, E., Rawson, T. M., Gill, D., Gilchrist, M., Naylor, N. R., & Holmes, A. H. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0603-6 · Cited by 62 · cited 1×
“used as a safety net to allay the surgeons fears of SSI and post-operative complications.(158) A systematic review of”
MethodSelf-citationFilling the gaps in the global prevalence map of clinical antimicrobial resistance
Oldenkamp, R., Schultsz, C., Mancini, E., & Cappuccio, A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013515118 · Cited by 61 · cited 1×
“drawn from many low- and middle-income countries are scarce.(12) In the surgical setting, antibiotic resistance (AR) leads to prolonged hospitalisation, extended durations of antibiotic therapy, higher rates of mortality, increased need for surgical”
BackgroundBull, A. L., Russo, P. L., Friedman, N. D., Bennett, N. J., Boardman, C. J., & Richards, M. J. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.01.018 · Cited by 60
Intravenous Push Administration of Antibiotics: Literature and Considerations
Spencer, S. H., Ipema, H. J., Hartke, P. L., Krueger, C., Rodriguez, R. W., Gross, A. E., & Gabay, M. P. (2018) · Hospital Pharmacy · doi:10.1177/0018578718760257 · Cited by 60 · cited 1×
“Typically, commencement of vancomycin and fluoroquinolone infusions commences 1-hour prior to surgical incision, as shortened infusions can cause adverse effects, including “red-man syndrome” with vancomycin and venous irritation with fluoroquinolones.(147) While standard infusion times may vary at an institutional le…”
BackgroundBedouch, P., Labarère, J., Chirpaz, E., Allenet, B., Lepape, A., Fourny, M., Pavèse, P., Girardet, P., Merloz, P., Saragaglia, D., et al. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502396 · Cited by 59
Savic, L. C., Khan, D. A., Kopač, P., Clarke, R. C., Cooke, P., Dewachter, P., Ebo, D. G., Garcez, T. P., Garvey, L., Guttormsen, A. B., et al. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.01.026 · Cited by 59 · cited 3×
“Consideration should be given where possible to implementation of prescreening “antibiotic allergy testing” patients in surgical preadmission clinics.(83) Development of a protocol for taking an accurate patient penicillin/cephalosporin allergy history was undertaken by Blumenthal et al, whereby patients deemed low ri…”
BackgroundInfluentialWhite, M. C., Peven, K., Clancy, O., Okonkwo, I., Bakolis, I., Russ, S., Leather, A. J. M., & Sevdalis, N. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003944 · Cited by 57 · cited 1×
“A recent systematic review found that the SSC is used with high fidelity in LMICs and strategies covering domains of training, adapting to context, provision of interactive assistance, stakeholder engagement and clinician support may offer solutions to augment implementation.(131) Encouragingly, several studies in LMI…”
BackgroundSelf-citationWhite, M. C., Randall, K., Ravelojaona, V., Andriamanjato, H. H., Andean, V., Callahan, J., Shrime, M. G., Russ, S. J., Leather, A. J. M., & Sevdalis, N. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-001104 · Cited by 55
Self-citationSaravolatz, L. D., Pawlak, J., & Johnson, L. B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis492 · Cited by 53 · cited 1×
“requiring antibiotic treatment with daptomycin, linezolid, ceftaroline or tigecycline.(42,45)”
Efficacy of one dose fluoroquinolone before prostate biopsy
Shandera, K. C., Thibault, G. P., & Deshon, G. E. (1998) · Urology · doi:10.1016/s0090-4295(98)00311-2 · Cited by 51 · cited 1×
“agents in urological procedures such as transrectal prostatic biopsy or for patients with confirmed β-lactam allergy (IgE mediated) to first-line agents.(72,73)”
BackgroundKavanagh, K. T., Cormier, L. E., Saman, D. M., & Abusalem, S. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-18 · Cited by 51 · cited 1×
“This strategy was seen after the emergence of MRSA, whereby prescreening for MRSA by the use of nasal swabs and subsequently patient isolation, decolonisation and tailored SAP has been adopted in some institutions.(136) A multi-site study conducted across a number of European countries showed that combinations of pres…”
MethodForrester, J. A., Koritsanszky, L. A., Amenu, D., Haynes, A. B., Berry, W. R., Alemu, S., Jiru, F., & Weiser, T. G. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.03.020 · Cited by 48 · cited 2×
“26).(30) While various studies have investigated the impact of SAP timing, there are many nuances within the surgical environment that can hinder appropriate timing of antibiotic administration.”
BackgroundSmall molecule ligands for oxytocin and vasopressin receptors
Freidinger, R. M., & Pettibone, D. J. (1997) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199701)17:1<17::aid-med2>3.0.co;2-w · Cited by 48
Segala, F. V., Murri, R., Taddei, E., Giovannenze, F., Vecchio, P. D., Birocchi, E., Taccari, F., Cauda, R., & Fantoni, M. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00814-6 · Cited by 47 · cited 1×
“001).(124) Cohen et al performed a large study across a cohort of 22,138 patients investigating the use of appropriate prophy-”
BackgroundCompliance with Local Guidelines for Antibiotic Prophylaxis in Surgery
Busom, M. P., Compaired, M. A., Delás, J., & Partearroyo, B. E. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502397 · Cited by 46 · cited 1×
“be improved by multidisciplinary engagement in the development and implementation of protocols.(127) The WHO recommend using a 19-step Surgical Safety Checklist (SSC) to capture critical tasks across three phases”
MethodNaik, B. I., Roger, C., Ikeda, K., Todorovic, M. S., Wallis, S. C., Lipman, J., & Roberts, J. A. (2017) · British Journal of Anaesthesia · doi:10.1093/bja/aex026 · Cited by 46 · cited 1×
“This is done to ensure serum and tissue concentrations exceed the microbial minimum inhibitory concentration (MIC) throughout the duration of surgery.(100,101) Common examples include procedure durations exceeding two half-lives of the SAP utilised or in procedures where there is excessive blood loss, exceeding 1500mL.”
BackgroundUse of Guideline-Based Antibiotic Prophylaxis in Women Undergoing Gynecologic Surgery
Wright, J. D., Hassan, K., Ananth, C. V., Herzog, T. J., Lewin, S. N., Burke, W. M., Lu, Y., Neugut, A. I., & Hershman, D. L. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182a8a36a · Cited by 45
Labricciosa, F. M., Sartelli, M., Correia, S., Abbo, L. M., Severo, M., Ansaloni, L., Coccolini, F., Alves, C. L., Melo, R. B., Baiocchi, G. L., et al. (2018) · World Journal of Emergency Surgery · doi:10.1186/s13017-018-0190-5 · Cited by 44 · cited 1×
“and that local guidelines were of greater use than national guidelines.(110) Key considerations for local guideline develop-”
Zhu, D., Li, Q., Shen, Y., & Zhang, Q. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0675-3 · Cited by 44
Singh, S., Mendelson, M., Surendran, S., Bonaconsa, C., Mbamalu, O., Nampoothiri, V., Boutall, A., Hampton, M., Dhar, P., Pennel, T., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.12.013 · Cited by 41 · cited 1×
“The issue of ownership of the antibiotic prescription or order is often not clear, particularly in surgical pathways where multiple healthcare professionals have a role to play.(155) The issue of ownership is”
BackgroundSelf-citationBonaconsa, C., Mbamalu, O., Mendelson, M., Boutall, A., Warden, C., Rayamajhi, S., Pennel, T., Hampton, M., Joubert, I., Tarrant, C., et al. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2020-012372 · Cited by 40 · cited 1×
“both peri- and post-operatively also impacts the infectionrelated care that patients receive, including SAP, and SSIrelated care.(160) Research is needed to identify effective mechanisms for interdisciplinary work across the surgical”
BackgroundSelf-citationMarkantonis, S. L., Kostopanagiotou, G. G., Panidis, D., Smirniotis, V., & Voros, D. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90025-2 · Cited by 39 · cited 1×
“concentrations above the MIC of the organism in serum and/ or tissue samples.(105) Optimising Current Practice Across Institutional Processes The increasing frequency of community transmission”
BackgroundBeyond surgical care improvement program compliance: antibiotic prophylaxis implementation gaps
Hawkins, R. B., Levy, S. M., Senter, C. E., Zhao, J. Y., Doody, K., Kao, L. S., Lally, K. P., & Tsao, K. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.02.009 · Cited by 37
White, M. C., Daya, L., Karel, F. K. B., White, G., Abid, S., Fitzgerald, A., Mballa, G. A. E., Sevdalis, N., & Leather, A. J. M. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004586 · Cited by 32
Self-citationPreventing Antimicrobial-Resistant Bacterial Infections in Surgical Patients
Raymond, D. P., Kuehnert, M. J., & Sawyer, R. G. (2002) · Surgical Infections · doi:10.1089/109629602762539599 · Cited by 31 · cited 3×
“The incidence of AMR is rapidly increasing and infection-related mortality is expected to exceed 10 million cases per year by 2050.1 Over the past decade, the emergence of AMR across fungal, viral, bacterial, and protozoal infections is increasingly reported.2 Resistance has been highlighted in recent times to various…”
BackgroundInfluentialIs screening patients for antibiotic-resistant bacteria justified in the Indian context?
Bhattacharya, S. (2011) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.83902 · Cited by 29 · cited 1×
“Screening patients for colonisation with MROs will have an increasing role.(106,107)”
BackgroundMahmoudi, L., Ghouchani, M., Mahi‐Birjand, M., Bananzadeh, A., & Akbari, A. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s212728 · Cited by 29
Telfah, S., Nazer, L. H., Dirani, M., & Daoud, F. (2015) · Sultan Qaboos University medical journal · doi:10.18295/squmj.2015.15.04.014 · Cited by 27 · cited 1×
“approach consisting of medical, pharmacy and nursing staff.(121,123,126) Despite successful implementation of these”
MethodA national audit of antibiotic prophylaxis in elective laparoscopic cholecystectomy
Graham, H. E., Vasireddy, A., & Nehra, D. (2014) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588414x13946184900688 · Cited by 25
Freitas, D. M., & Moreira, D. M. (2019) · Arab Journal of Urology · doi:10.1080/2090598x.2019.1592636 · Cited by 23 · cited 1×
“Recommendations for fosfomycin in transrectal prostate biopsy are supported by a meta-analysis, which shows improved patient outcomes compared with ciprofloxacin standard of care, although data in this meta-analysis came from some countries with high rates of ciprofloxacin resistance.(142) Additionally, increasing flu…”
ResultPractice Changes to Improve Delivery of Surgical Antibiotic Prophylaxis
Zvonar, R. K., Bush, P., & Roth, V. R. (2008) · Healthcare Quarterly · doi:10.12927/hcq.2008.19664 · Cited by 19
Viamonte, K. R., Tames, A. S., Correa, R. A. S., Manteca, M. V. R., & Martín‐Suárez, A. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00843-1 · Cited by 19
Antimicrobial therapy in obesity: a multicentre cross-sectional study
Charani, E., Gharbi, M., Frost, G. S., Drumright, L. N., & Holmes, A. H. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv189 · Cited by 16 · cited 1×
“A cross-sectional study in the UK revealed approximately one in five inpatients were obese and those receiving antibiotics typically required more complicated dosing than non-obese patients.(92) Obesity influences the pharmacokinetic disposition of common antibiotics used in SAP by alterations in volume of distributio…”
BackgroundSelf-citationKnox, M. C., & Edye, M. (2015) · Surgical Infections · doi:10.1089/sur.2015.195 · Cited by 16 · cited 1×
“Timing of antibiotic administration remains a challenging component of SAP and clinical practice can be divergent with key guidelines.(149) Studies have shown improved timing of antibiotic administration fol-”
BackgroundPhillips, C. J., Gilchrist, M., Cooke, F. J., Franklin, B. D., Enoch, D., Murphy, M. E., Santos, R., Brannigan, E., & Holmes, A. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026624 · Cited by 13 · cited 1×
“A recent multicentre UK study of hospitalised patients with common infections found that two-thirds of those patients with documented penicillin allergy had no details recorded on their purported allergy.(82) Similarly, in the perioperative setting, a UK study of over 21,000 elective surgical patients found that 27% o…”
BackgroundSelf-citationRibed, A., Monje, B., García‐González, X., Sánchez-Somolinos, M., Sanz-Ruíz, P., Rodríguez, C., & Sanjurjo‐Sáez, M. (2018) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2018-001666 · Cited by 12 · cited 1×
“approach consisting of medical, pharmacy and nursing staff.(121,123,126) Despite successful implementation of these”
MethodHaney, V., Maman, S. R., Prozesky, J., Bezinover, D. S., & Karamchandani, K. (2020) · BMJ Open Quality · doi:10.1136/bmjoq-2020-001042 · Cited by 12 · cited 1×
“approach consisting of medical, pharmacy and nursing staff.(121,123,126) Despite successful implementation of these”
MethodAdherence to surgical antibiotic prophylaxis guidelines in children: A cohort study
Rizvi, Z. M., Palasanthiran, P., Wu, C., Mostaghim, M., & McMullan, B. J. (2019) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.14484 · Cited by 11
Narasimhaiah, M. H., Asrani, J. Y., Palaniswamy, S. M., Bhat, J. J., George, S. E., Srinivasan, R., Vipra, A. A., Desai, S. N., Junjappa, R. P., Roy, P., et al. (2013) · Advances in Microbiology · doi:10.4236/aim.2013.31008 · Cited by 10
Fluoroquinolone-Resistant Pseudomonas aeruginosa in Chronic Rhinosinusitis
Guss, J., Doghramji, L. J., Edelstein, P. H., & Chiu, A. G. (2009) · ORL · doi:10.1159/000242428 · Cited by 9 · cited 1×
“aeruginosa SSI post endoscopic sinus surgery.(143)”
White, M. C., Leather, A. J. M., Sevdalis, N., & Healey, A. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004498 · Cited by 7 · cited 2×
“A recent systematic review found that the SSC is used with high fidelity in LMICs and strategies covering domains of training, adapting to context, provision of interactive assistance, stakeholder engagement and clinician support may offer solutions to augment implementation.131 Encouragingly, several studies in LMICs…”
MethodInfluentialSelf-citationContinued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
Gern, B. H., Greninger, A. L., Weissman, S. J., Stapp, J. R., Tao, Y., & Qin, X. G. (2018) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-018-0257-x · Cited by 5 · cited 1×
“first-line narrow spectrum penicillins and cephalosporins (flucloxacillin, nafcillin, cefazolin).(16,35) While the long-”
Background(2017) · PubMed Central
Research works printed but not linked: 11
- Centers for Disease Control and Prevention. Surgical site infection event. National Healthcare Safety Network; 2021:1–39.
- 2021, StatPearls [Internet]
- 2021, UpToDate
- Malabarba, 1997, Med Res Rev, 17, 69, 10.1002/(sici)1098-1128(199701)17:1<69::aid-med3>3.0.co;2-r · doi:10.1002/(sici)1098-1128(199701)17:1<69::aid-med3>3.0.co;2-r
- McGuinness, 2017, Yale J Biol Med, 90, 269
- Oliphant, 2002, Am Fam Physician, 65, 455
- Scher, 1997, Am Surg, 63, 59
- Australian Commission on Safety and Quality in Health Care. Antimicrobial prescribing practice in Australian Hospitals: results of the 2019 Hospital National Antimicrobial Prescribing survey; 2021:1–45.
- Abdel-Aziz, 2013, Adv Pharmaco Sci, 2013, 842593
- World Health Organization. WHO surgical site infection prevention guidelines web appendix 4. Summary of a systematic review on screening for extended spectrum beta-lactamase and the impact on surgical antibiotic prophylaxis. Geneva; 2018.
- Davey, 2017, Cochrane Database Syst Rev, 2, CD003543
Cited by
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
“In surgical settings, antibiotic prophylaxis prevents surgical site infections (SSIs), but increasing AMR raises the risk of SSIs complicated by resistant bacteria, leading to poorer outcomes [256].”
Godman, B., Egwuenu, A. J., Wesangula, E., Schellack, N., Kalungia, A. C., Tiroyakgosi, C., Kgatlwane, J., Mwita, J. C., Okwen, P., Niba, L. L., et al. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2106368 · Cited by 161
Righi, E., Mutters, N. T., Guirao, X., del Toro, M. D., Eckmann, C., Friedrich, A. W., Giannella, M., Kluytmans, J. A. J. W., Presterl, E., Christaki, E., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.12.012 · Cited by 125
Dhole, S., Mahakalkar, C. C., Kshirsagar, S., & Bhargava, A. (2023) · Cureus · doi:10.7759/cureus.47858 · Cited by 172
“Antibiotics help prevent the development of deep tissue and organ/space infections by containing bacteria at the incision site [37].”
BackgroundInfluentialCefiderocol: Clinical application and emergence of resistance
Wang, L., Zhu, J., Chen, L., & Du, H. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101034 · Cited by 67
Metadata
- Authors
- Menz, B. D., Charani, E., Gordon, D. L., Leather, A. J., Moonesinghe, S. R., & Phillips, C. J.
- Affiliations
- Flinders Medical Centre (AU)
- University of Cape Town (ZA)
- Flinders University (AU)
- King's College London (GB)
- Corresponding author
- Phillips, Cameron J
- Venue
- Infection and Drug Resistance
- Publisher
- Informa UK Limited
- Published
- 2021-12
- Volume
- Volume 14
- Pages
- 5235-5252
- ISSN
- 1178-6973 (ISSN-L)
- PMC
- PMC8665887
- OpenAlex
- W4200384512
- Cited by
- 118
- References
- 159
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 20 · 2023: 30 · 2022: 16
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Infection and Drug Resistance (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion, cc-by-nc)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (HPRU-2012-10047)
- Public Health England (HPRU-2012–10047)
- Economic and Social Research Council (ES/P008313/1)
- Topics
- Health Sciences › Medicine › Surgery › Surgical site infection prevention
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- surgical antibiotic prophylaxis, antimicrobial resistance, drug-resistant bacteria, surgical site infection, nosocomial infections, perioperative care, antibiotic stewardship, surgical outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

